首页> 外文会议>International Symposium on Eco-Materials Processing and Design >Preparation of the Nano-hydroxyapatite /Chitosan / Konjac glucomannan Composite as a Novel Degradable Drug Delivery System
【24h】

Preparation of the Nano-hydroxyapatite /Chitosan / Konjac glucomannan Composite as a Novel Degradable Drug Delivery System

机译:纳米羟基磷灰石/壳聚糖/ Konjac Glucomannan复合材料作为一种新型可降解药物递送系统

获取原文

摘要

Nano-hydroxyapatite (n-HA)/chitosan (CS)/konjac glucomannan (KGM) composite was prepared by integrating composition and molding. Then, X-ray diffraction (XRD) and scanning electron microscopy (SEM) were used to analyze the physical, chemical and degradable properties of the composite before and after in simulated body fluid (SBF). Moreover, study in vitro test for drug delivery revealed that the amount of released pentoxifylline (1-[5-oxohexyl]-3,7-dimethylxanthine)(PTX) reached a plateau and equaled 80% of the drug loaded in an implant. The newly develop n-HA/CS/KGM composite may serve as a good degradable biomaterial for implantable drug delivery system (IDDS) in bone tissue engineering.
机译:通过整合组合物和模塑制备纳米羟基磷灰石(N-HA)/壳聚糖(CS)/ Konjac葡糖胺(KGM)复合材料。然后,使用X射线衍射(XRD)和扫描电子显微镜(SEM)来分析模拟体液(SBF)之前和之后的复合物的物理,化学和可降解性能。此外,研究药物递送的体外试验表明,释放的氟诺酶(1- [5-氧己基] -3,7-二甲基黄嘌呤)(PTX)的量达到了平台并等于植入物中的80%的药物。新开发的N-HA / CS / KGM复合材料可作为骨组织工程中可植入药物递送系统(IDDS)的良好可降解生物材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号